# Omeros Corporation (OMER): MoatMap facts

As of 27 Oct 2026. Research data, not investment advice.

As of 27 Oct 2026, MoatMap's StockRank for Omeros Corporation (OMER) is 39/100, ranked against 24,000+ stocks in 35 markets (Quality 31, Value 36, Momentum 62, each scored against its sector).

- StockRank: 39/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 31, Value 36, Momentum 62: each a 0-100 percentile within Healthcare.
- Position: #16,150 overall, #1,402 in Healthcare.
- Listing: United States, NGM; Healthcare / Biotechnology.
- Last close: 16.29 USD on 26 Oct 2026.
- Insider filings, last 180 days: directors sold USD 2.1M.
- Buybacks, last 180 days: the company bought back USD 9.9M on 1 day.

Source: https://moatmap.ai/stock/OMER
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker